Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerRecruiting
NCT05365581Phase 1Updated Jul 15, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Gastric Adenocarcinoma · Gastroesophageal Junction (GEJ) Adenocarcinoma · Pancreatic Adenocarcinoma
United States, China, France, Italy, Japan +3 more
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral SclerosisCompleted
NCT04176224Phase 1Updated Jul 15, 2026
Sponsor: Shionogi
Japanese Patients With ALS
Japan
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsActive Not Recruiting
NCT06533059Phase 1Updated Jul 15, 2026
Sponsor: Alterome Therapeutics, Inc.
Cancer · Breast Cancer · Endometrial Cancer · Metastatic Cancer
United States, Australia, France, Japan, South Korea +3 more
Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult SubjectsCompleted
NCT04493281Phase 1Updated Jul 15, 2026
Sponsor: Shionogi
Healthy Adult Subjects
Japan
Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)Completed
NCT05679570Phase 2Updated Jul 15, 2026
Sponsor: International University of Health and Welfare
Pulmonary Arterial Hypertension
Japan
A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With ChemotherapyTerminated
NCT06528093Phase 1Updated Jul 15, 2026
Sponsor: Boehringer Ingelheim
Pancreatic Ductal Adenocarcinoma
United States, Belgium, France, Germany, Japan +1 more
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)Completed
NCT05342597Phase 1Updated Jul 15, 2026
Sponsor: Shionogi
Healthy Adult Subjects
Japan
Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal ImpairmentCompleted
NCT03289208Phase 1Updated Jul 15, 2026
Sponsor: Shionogi
Renal Impairment · Healthy
Japan
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)Recruiting
NCT07286331Phase 3Updated Jul 15, 2026
Sponsor: GlaxoSmithKline
Neoplasms, Endometrial
Argentina, Australia, Canada, Japan, Panama
A Study of TAK-360 in Adults With Idiopathic HypersomniaRecruiting
NCT06812078Phase 2Updated Jul 15, 2026
Sponsor: Takeda
Idiopathic Hypersomnia
United States, France, Hong Kong, Italy, Japan +1 more
A Study of ONO-1110 in Patients With Postherpetic NeuralgiaCompleted
NCT06708416Phase 2Updated Jul 15, 2026
Sponsor: Ono Pharmaceutical Co., Ltd.
Postherpetic Neuralgia
Japan
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not Yet Recruiting
NCT07521670Phase 2Updated Jul 15, 2026
Sponsor: National Cancer Centre, Singapore
Recurrent Adenoid Cystic Carcinoma · Adenoid Cystic Carcinoma Metastatic · Papillary Thyroid Carcinoma
Japan, Malaysia, Singapore, South Korea
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)Completed
NCT04481789Phase 1Updated Jul 15, 2026
Sponsor: Shionogi
Healthy Adult Subjects
Japan
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular CarcinomaActive Not Recruiting
NCT03778957Phase 3Updated Jul 15, 2026
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Australia, Brazil, Canada, China +13 more
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerActive Not Recruiting
NCT03456076Phase 3Updated Jul 15, 2026
Sponsor: Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
United States, Australia, Austria, Belarus, Bosnia and Herzegovina +22 more
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)Not Yet Recruiting
NCT07680790Phase 3Updated Jul 15, 2026
Sponsor: Bristol-Myers Squibb
Non-Small Cell Lung Cancer
United States, Argentina, Australia, Brazil, Canada +10 more
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian CancerRecruiting
NCT07278336Phase 1Updated Jul 15, 2026
Sponsor: AbbVie
Ovarian Cancer
United States, China, Israel, Japan, New Zealand +1 more
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerRecruiting
NCT07570979Phase 1Updated Jul 14, 2026
Sponsor: Novartis Pharmaceuticals
Metastatic Castration-resistant Prostate Cancer (mCRPC)
United States, Australia, Japan
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughActive Not Recruiting
NCT05600777Phase 3Updated Jul 14, 2026
Sponsor: Bellus Health Inc. - a GSK company
Cough · Refractory Chronic Cough
United States, Australia, Canada, China, Czechia +8 more
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic CancerActive Not Recruiting
NCT03816163Phase 2Updated Jul 14, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Pancreatic Cancer · Metastatic Pancreatic Cancer · Metastatic Pancreatic Adenocarcinoma
United States, Australia, Brazil, China, France +8 more
A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCActive Not Recruiting
NCT04995523Phase 1, Phase 2Updated Jul 14, 2026
Sponsor: AstraZeneca
Non-Small-Cell Lung Carcinoma
United States, Australia, Belgium, Brazil, China +11 more
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 YearsRecruiting
NCT06810505Phase 3Updated Jul 14, 2026
Sponsor: AbbVie
Chronic Migraine
United States, Canada, Denmark, Hungary, Italy +6 more
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerActive Not Recruiting
NCT02032823Phase 3Updated Jul 14, 2026
Sponsor: AstraZeneca
Breast Cancer
United States, Argentina, Australia, Austria, Belgium +19 more
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaRecruiting
NCT06921785Phase 3Updated Jul 14, 2026
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Australia, Brazil, Canada, China +15 more
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerRecruiting
NCT06282575Phase 3Updated Jul 14, 2026
Sponsor: Jazz Pharmaceuticals
Biliary Tract Cancer
United States, Argentina, Belgium, Brazil, Canada +20 more

Previous page Next page